Risk of systemic infections requiring hospitalization in children with atopic dermatitis: a Danish retrospective nationwide cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

Background: Infections can trigger worsening of atopic dermatitis (AD). Objectives: To examine whether hospital-managed paediatric AD is associated with increased risk of extracutaneous infections requiring hospitalization in childhood. Methods: A nationwide-based cohort study using Danish registries was done. Children aged < 18 years with a hospital diagnosis of AD and children without a hospital diagnosis of AD were sex- and age-matched at date of AD diagnosis. Study outcomes were extracutaneous infections that led to hospitalization. AD severity was defined according to prescriptions for treatments. Results: Of 19 415 children with AD [median follow-up 7·4 years; interquartile range (IQR) 3·3–13.3] and 194 150 without AD (median follow-up 7·7 years; IQR 3·6–13·5), 56% were boys and 50% were aged < 2 years. Children with AD had an increased rate of lower respiratory [LRTI; adjusted hazard ratio (aHR) 1·79, 95% confidence interval (CI) 1·65–1·94)], upper respiratory (URTI; aHR 1·59, 95% CI 1·34–1·88), urinary tract (UTI; aHR 1·34, 95% CI 1·16–1·54), musculoskeletal (MSSI; aHR 1·33, 95% CI 1·06–1·66) and gastrointestinal infections (GITIs; aHR 1·24, 95% CI 1·14–1·35) vs. children without AD. Associations did not clearly vary with AD severity. Absolute risk difference per 10 000 person-years was 26·4 (95% CI 23·0–29·8) for LRTIs, 3·1 (95% CI 1·6–4·7) for URTIs, 3·6 (95% CI 1·8–5·4) for UTIs, 0·9 (95% CI 0·2–2·0) for MSSIs and 8·7 (95% CI 5·7–11·7) for GITIs. Conclusions: Children with hospital-managed AD have an increased risk of systemic infections that lead to hospitalization; absolute risk is generally low.

OriginalsprogEngelsk
TidsskriftBritish Journal of Dermatology
Vol/bind185
Udgave nummer1
Sider (fra-til)119-129
Antal sider11
ISSN0007-0963
DOI
StatusUdgivet - 2021

Bibliografisk note

Funding Information:
sources The study was supported by a research grant from the International Society of Atopic Dermatitis (ISAD).The authors are grateful to the Fondation de la Dermatite Atopique, the Coll?ge des Enseignements en Dermatologie (CEDEF) and the International Society of Atopic Dermatitis for their support.

Publisher Copyright:
© 2021 British Association of Dermatologists

ID: 302166223